A Phase Ii Trial Of Bortezomib Added To Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, And Prednisone In Patients With Previously Untreated Indolent Non-Hodgkin'S Lymphoma
BLOOD(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
BLOOD(2014)